ABSTRACT. In this paper, we propose and analyze three viral infection models with humoral immunity including an eclipse stage of infected cells. The incidence rate of infection is represented by bilinear incidence and saturated incidence in the first and second models, respectively, while it is given by a more general function in the third one. The neutralization rate of viruses is giv0en by bilinear form in the first two models, while it is given by a general function in the third one. For each model, we have derived two threshold parameters, the basic infection reproduction number which determines whether or not a chronic-infection can be established without humoral immunity and the humoral immune response activation number which determines whether or not a chronic-infection can be established with humoral immunity. By constructing suitable Lyapunov functions we have proven the global asymptotic stability of all equilibria of the models. For the third model, we have established a set of conditions on the threshold parameters and on the general functions which are sufficient for the global stability of the equilibria of the model. We have performed some numerical simulations for the third model with specific forms of the incidence and neutralization rates and have shown that the numerical results are consistent with the theoretical results.
INTRODUCTION
During the last decades, several dangerous viruses have been appeared which attack the human body and some of them causes death. These prompt many researchers to study mathematical modeling and model analysis of the interaction between the host cells and viruses such as human immunodeficiency virus (HIV) (see e.g. [1] - [12] ), hepatitis B virus (HBV) [13] - [15] , hepatitis C virus (HCV) [16] - [18] , human T cell leukemia virus (HTLV) [19] and dengue virus [20] , etc. There are many benefits from mathematical models of viral infection including: (i) they provide important quantitative insights into viral dynamics in vivo, (ii) they can improve diagnosis and treatment strategies which raise hopes of patients infected with viruses, (iii) they can be used to estimate key parameter values that control the infection process.
The basic viral infection model which was proposed by Nowak and Bangham [2] is a three dimensional ODEs and contains three variables x, y and v representing the concentrations of the uninfected target cells, infected cells and free virus particles, respectively. To provide more accurate modelling for the viral infection, the effect of immune response has to be considered. The immune system has two main responses to viral infections, the cell mediated immunity and humoral immunity. The cell mediated immunity is based on the Cytotoxic T Lymphocyte (CTL) cells which are responsible to attack and kill the infected cells. The humoral immunity is based on the antibodies that are produced by the B cells. The function of the antibodies is to attack the viruses [1] . In some infections such as in malaria, the cell mediated immunity is less effective than the humoral immunity [21] . In the literature, several mathematical models have been appeared to consider the humoral immune response into the viral infection models (see e.g. [22] - [28] ). The basic model of viral infection with humoral immune response is given by [22] , [28] :ẋ
3) z = gzv − μz, (1.4) where z denotes the concentration of the B cells. Parameters λ, k and g represent, respectively, the rate at which new healthy cells are generated from the source within the body, the generation rate constant of free viruses produced from the infected cells and the proliferation rate constant of B cells. Parameters d, a, c and μ are the natural death rate constants of the uninfected cells, infected cells, free virus particles and B cells, respectively. Parameter β is the infection rate constant and r is the neutralization rate constant of viruses. All the parameters given in model (1.1)-(1.4) are positive. Model (1.1)-(1.4), does not take into consideration an eclipse stage of infected cells (such cells are called latently infected cells which contain the viruses but not producing it) which is due to the delay between the moment of infection and the moment when the infected cell becomes active to produce new infectious viruses. Latently infected cells have been incorporated into viral infection models in [3] and [29] . The global stability of viral infection models with latently infected cells has been studied in several works (see e.g. [9] , [30] and [31] ). However, in [9] , [30] and [31] , the humoral immune response has been neglected.
Our objective in this paper is to propose a class of viral infection models with humoral immune response taking into consideration both latently and actively infected cells and investigate their basic and global properties. The incidence rate of infection is represented by bilinear infection rate and saturation functional response in the first and second model, respectively, while it is given by a general function in the third one. The neutralization rate of viruses is given by bilinear form in the first two models, while it is given by a general function in the third one. Using Lyapunov functions, we show that the global dynamics of the first two models are determined by two threshold parameters, the basic infection reproduction number and the humoral immune response activation number. For the third model, we derive two threshold parameters and show that, under a set of conditions on these parameters and on the general functions, all the equilibria of the model are globally asymptotically stable (GAS).
MODEL WITH BILINEAR INCIDENCE RATE
In this section, we propose a viral infection model with humoral immune response, taking into account the latently infected and actively infected cells.
2)
where w and y are the concentrations of latently and actively infected cells, respectively. Eq. (2.2) describes the dynamics of the latently infected cells and shows that they are converted to actively infected cells with rate constant b. The parameters e and a are the death rate constants of the latently and actively infected cells, respectively. The fractions (1 − α) and α with 0 < α < 1 are the probabilities that upon infection, an uninfected cell will become either latently infected or actively infected. The other variables and parameters of the model have the same definitions as given in Section 1. Model (2.1)-(2.5) may describe the dynamics of several viruses such as HIV, HBV and HCV. In case of HIV, x will represent the concentration of the uninfected CD4 + T cells, while in case of HBV or HCV it represents the hepatocyte cells.
Positive invariance.
We note that, model (2.1)-(2.5) is biologically acceptable in the sense that no population goes negative. It is straightforward to check the positive invariance of the non-negative orthant R 5 ≥0 by model (2.1)-(2.5) (see e.g. [11] and [29] ). In the following, we show the boundedness of the solutions of model (2.1)-(2.5). Proposition 1. There exist positive numbers L i , i = 1, 2, 3 such that the compact set
where
On the other hand, let
where 
, then there exist only two positive equilibria E 0 ∈ Ω and E 1 ∈ Ω, and
where
• Ω is the interior of Ω. Proof. Let the right-hand sides of Eqs. (2.1)-(2.5) equal to zero, then we get that system (2.1)-(2.5) can admit three equilibria:
, which represents the state where the viruses are absent.
(ii) Chronic-infection equilibrium without humoral immune response
, where
which represents the basic infection reproduction number and determines whether or not a chronic-infection can be established without humoral immune response. In terms of R B 0 , we can write the components of E 1 as:
Thus, if R B 0 > 1, then E 1 exists and the infection becomes chronic without humoral immunity.
(iii) Chronic-infection equilibrium with humoral immune response E 2 = (x 2 , w 2 , y 2 , v 2 , z 2 ), where
which represents the humoral immune response activation number and determines whether or not a persistent humoral immune response can be established. Then we can write z 2 = c r
In this case, the infection becomes chronic with humoral immunity. Clearly,
From the equilibrium conditions of E 1 we have
From the steady state condition of E 2 , we have
and then 
0 along the trajectories of (2.1)-(2.5) is given by:
Thus, the solutions of system (2.1)-(2.5) converge to Γ, the largest invariant subset of 
Proof. We construct the following Lyapunov function
dt along the trajectories of (2.1)-(2.5) we get
Applying λ = dx 1 + βx 1 v 1 and collecting terms of Eq. (2.8) we obtain
Using the equilibrium conditions for E 1 :
We have
Since the geometrical mean is less than or equal to the arithmetical mean, then
Thus, the solutions of system (2.1)-(2.5) limit to the largest invariant subset of
. It can be seen that,
and z(t) = 0. Applying LaSalle's invariance principle we obtain that, E 1 is GAS.
We note that, W B 2 (x, w, y, v, z) > 0 for all x, w, y, v, z > 0, while W B 2 (x, w, y, v, z) reaches its global minimum at E 2 . Calculating the time derivative of W B 2 along the trajectories of
Applying λ = dx 2 + βx 2 v 2 , then Eq. (2.9) becomes:
Using the equilibrium conditions for E 2
we obtain
Using the relation between arithmetical and geometrical means, we get
The global stability of E 2 follows from LaSalle's invariance principle.
Remark 1. The parameter R B
0 is the standard basic infection reproduction number in the literature of viral infection models. It measures the average number of newly infected cells produced from any one infected cell at the infection-free equilibrium [1] . Thus, R B 0 is the threshold parameter that determines whether or not a chronic-infection can be established without humoral immune response. If R B 0 ≤ 1, then the viruses will be cleared from the body. Therefore, using effective antiviral drug therapy can control and prevent the infection by making R B 0 ≤ 1. In case of R B 0 > 1, the infection becomes chronic. The parameter R B 1 represents the humoral immune response activation number and determines whether or not a persistent humoral immune response can be established. When R B 1 ≤ 1 < R B 0 , the infection always becomes chronic, but no humoral immune response can be established. When R B 1 > 1, the infection always becomes chronic with humoral immune response.
MODEL WITH SATURATION FUNCTIONAL RESPONSE
In model (2.1)-(2.5), we have assumed that, the incidence rate between the uninfected target cells and viruses is given by bilinear, i.e., the infection rate per virus and per uninfected cell is constant. However, this bilinear incidence rate may not completely describe the interaction process between the viruses and uninfected target cells [33] , [34] . In some cases, the saturated incidence is more reasonable than the bilinear one (see [24] , [35] and [36] ). In this section, we modify model (2.1)-(2.5) by assuming that the incidence rate is given by saturation functional response.ẋ
where η > 0 is the saturation constant, and all the variables and parameters of the model have the same meanings as given previously. We note that the compact set Ω defined in Section 2 is also positively invariant with respect to system (3.1)-(3.5).
Lemma 2. For system (3.1)-(3.5) there exist two threshold parameters R S 0 > 0 and
, then there exist only two positive equilibria E 0 ∈ Ω and E 1 ∈ Ω, and (iii) if R S 1 > 1, then there exist three positive equilibria E 0 ∈ Ω, E 1 ∈ Ω and E 2 ∈
• Ω. Proof. Similar to the proof of Lemma 1, one can show that system (3.1)-(3.5) admits three equilibria: infection-free equilibrium E 0 = (x 0 , 0, 0, 0, 0), where x 0 = λ/d; chronic-infection equilibrium without humoral immune response E 1 = (x 1 , w 1 , y 1 , v 1 , 0) ; chronic-infection equilibrium with humoral immune response E 2 = (x 2 , w 2 , y 2 , v 2 , z 2 ) where,
and
are the basic infection reproduction number and the humoral immune response activation number, respectively. It is clear that R S 1 < R S 0 . It is seen that, E 0 is usually exists, E 1 exists when R S 0 > 1, and E 2 exists when R S 1 > 1. Moreover, it can be easily show that, E 0 , E 1 ∈ Ω and
3.1. Global stability. In this subsection, we are concerned with the global stability of the three equilibria of system (3.1)-(3.5). The strategy of the proofs is based on constructing suitable Lyapunov functions and applying LaSalle's invariance principle.
Define a Lyapunov function W S 0 as follows:
Similar to the previous section, one can easily show that,
We consider the following Lyapunov function
dt along the solutions of system (3.1)-(3.5), we get
Applying the condition λ = dx 1 +
Using the following equilibrium conditions for E 1
We have ηv 1 )(1 + ηv) ,
dt can be written as:
Since the geometrical mean is less than or equal to the arithmetical mean, then the third and fourth terms of Eq. 
The time derivative of W S 2 along the trajectories of system (3.1)-(3.5) is given by
Using the other equilibrium conditions for E 2 :
and thus,
If follows that, if R S 1 > 1, then x 2 , w 2 , y 2 , v 2 , z 2 > 0. Similar to the proof of Theorem 3, one can show that E 2 is GAS.
MODEL WITH GENERAL INCIDENCE AND NEUTRALIZATION RATES
In this section, we propose a viral infection model with latently infected cells and humoral immune response. We assume that the contacts between the viruses and uninfected target cells are given by an incidence function f (x, v). This form of incidence rate is general to encompass several forms of commonly used incidence rates such as bilinear incidence βxv [22] , [28] , saturated incidence βxv 1+ηv [25] and nonlinear incidence in the form f (x, v)v [27] . In [34] and [37] , the viral infection models with general incidence rate f (x, v) have been studied, but without taking the humoral immune response into consideration. Further, we assume that the neutralization rate of viruses and the activation rate of B cells are given by rvh(z) and gvh(z), respectively, where h(z) is a general nonlinear function. These forms can be seen as a generalization of the widely used bilinear forms qzv and rzv that appear in several papers (see e.g. [22] - [28] ). Furthermore, we assume that the removal rate of the B cells is given by a general function μh(z) which generalizes the linear removal rate μz presented in [22] - [28] . Based on the above considerations, we propose the following model:
Functions f and h are continuously differentiable and satisfy the following assumptions:
Positive invariance. Proposition 2.
Assume that Assumptions A1 and A3 are satisfied, then there exist positive numbers M i , i = 1, 2, 3 such that the compact set
is positively invariant. Proof. We haveẋ 
(t), w(t), y(t)
Equilibria and biological thresholds.
In this subsection, we calculate the equilibria of model (4.1)-(4.5) and derive two threshold parameters. 
, then there exist only two positive equilibria E 0 ∈ Ω 1 and E 1 ∈ Ω 1 , and E(x, w, y, v, z) be any equilibrium of system (4.1)-(4.5) satisfying the following equations: .13) we obtain w and y as: 
Let us define a function Ψ 1 as:
It is clear from Assumption 1 that, Ψ 1 (0) = 0, and when
Since Ψ 1 (v) is continuous for all v ≥ 0, then we have
From Assumption A1 we have Eq. (4.11) and define a function Ψ 2 as:
Using Assumption A1 we have Ψ 2 (0) = λ > 0 and Ψ 2 (x 0 ) = −f (x 0 , v 1 ) < 0. Since f is a strictly increasing function of x, then Ψ 2 is a strictly decreasing function of x, and there exists a unique x 1 ∈ (0, x 0 ) such that Ψ 2 (x 1 ) = 0. It follows that,
It means that, a chronic-infection equilibrium without humoral immune response E 1 = (x 1 , w 1 , y 1 , v 1 , 0) exists when k(eα+b) ac (e+b) ∂f (x 0 ,0) ∂v > 1. Now we are ready to define the basic infection reproduction number as:
The other possibility of Eq. 
According to Assumption A1, Ψ 3 is a strictly decreasing function of x. Clearly,
It follows from Eqs. (4.12)-(4.14) that,
Clearly, w 2 , y 2 > 0. Since h is continuous and strictly increasing function with h(0) = 0, then h −1 exists and it is also continuous and strictly increasing [38] . Thus, if
We define the humoral immune response activation number as:
Hence, z 2 can be rewritten as z 2 = h −1 c r (R G 1 − 1) . It follows that, there exists a chronicinfection equilibrium with humoral immune response E 2 = (x 2 , w 2 , y 2 , v 2 , z 2 ) when R G 1 > 1. Assumptions A1 and A2 imply that
Similar to the proof of Lemma 1, one can show that
From the equilibrium conditions of E 2 , we have
It follows that, E 2 ∈
• Ω 1 .
4.3.
Global stability analysis. In this subsection, we establish the global stability of the three equilibria of system (4.1)-(4.5) employing the direct Lyapunov method and LaSalle's invariance principle. To do so we need the following condition:
Theorem 7. For system (4.1)-(4.5), assume that Assumptions A1-A3 hold and that
Proof. Define a Lyapunov functional W G 0 as follows:
We note that,
Based on Assumption A2, the first term of Eq. (4.20) is less than or equal to zero. Therefore,
Similar to the Section 2, one can show that E 0 is GAS.
Lemma 4. Suppose that Assumptions A1-A4 are satisfied and
Using Assumption A4 with i = 1, x = x 1 and v = v 2 , we get
It follows from inequality (4.22) that
. Using the conditions of the equilibria E 1 and E 2 we have
and from inequalities (4.21) and (4.22) we get:
which leads to a contradiction. Thus, sgn (x 2 − x 1 ) = sgn (v 1 − v 2 ) . Using the equilibrium conditions for E 1 we have
From inequalities (4.21) and (4.23) we get sgn
Theorem 8. For system (4.1)-(4.5), assume that Assumptions A1-A4 hold and that
Proof. We construct the following Lyapunov functional w 1 , y 1 , v 1 , 0) = 0 and its time derivative along the trajectories of (4.1)-(4.5) is given by
Applying λ = dx 1 + f (x 1 , v 1 ) and collecting terms of Eq. (4.24) we get
and thus stability of E 1 .
Theorem 9. For system (4.1)-(4.5), suppose that Assumptions A1-A4 are satisfied and
We calculate the time derivative of W G 2 along the trajectories of (4.1)-(4.5) as:
Applying λ = dx 2 + f (x 2 , v 2 ) and collecting terms of Eq. (4.27) we get
NUMERICAL SIMULATIONS
In this section, we will perform some numerical simulations to confirm our theoretical results. Let us consider the following model: 5) where
Before performing numerical simulations we have to verify Assumptions A1-A4. We have
.
It follows that, Assumption A2(ii) is satisfied. Moreover,
Since, 0 < n 1 ≤ 1, then we have
Thus, Assumption A4 is satisfied. Clearly, function h(z) = z satisfies Assumption A3. Thus the global stability results demonstrated in Theorems 7-9 are valid for model (5.1)-(5.5).
For model (5.1)-(5.5), the parameters R G 0 and R G 1 are given by
. Now, we show some numerical results for model (5.1)-(5.5). In Table 1 , we provide the values of some parameters of model (5.1)-(5.5). The effect of the other parameters, β and g on the dynamical behavior of the system will be discussed below in detail. All computations are carried out by MATLAB. We use three sets of the parameters β and g to get the following three cases. Case (I): In this case we choose β = 0.01 and g = 0.001. For this set of parameters, the values of R G 0 and R G 1 are given by R G 0 = 0.318 < 1 and R G 1 = 0.114 < 1. Figures 1-5 show that, the states of the system eventually approach the infection-free equilibrium E 0 = (1000, 0, 0, 0, 0) for the three initial conditions IC1-IC3. This supports the results of Theorem 7 that the infection-free equilibrium E 0 is GAS. In this case, the virus particles will be cleared from the body. Case (II): By taking β = 0.055 and g = 0.001. With such choice we get, R G 1 = 0.226 < 1 < R G 0 = 1.748. Consequently, based on Lemma 3 and Theorem 8, the system has two equilibria E 0 and E 1 , and E 1 is GAS. Figures 1-5 show that the numerical simulations confirm our theoretical result given in Theorem 8. It can be observed that, the states of the system eventually converge to the chronic-infection equilibrium without humoral immune response E 1 = (592.991, 9.250, 38.851, 12.950, 0) for the three initial conditions IC1-IC3. In such case, the infection becomes chronic but with no persistent humoral immune response.
Case (III): We choose, β = 0.045 and g = 0.01. Then, we calculate R G 0 = 1.43 > 1 and R G 1 = 1.023 > 1. This means that, the system has three equilibria E 0 , E 1 and E 2 based on Lemma 3. Moreover, from Theorem 9, E 2 is GAS. From Figures 1-5 , we can see that, our simulation results are consistent with the theoretical results of Theorem 9. We observe that, the states of the system converge the chronic-infection equilibrium with humoral immune response E 2 = (765.415, 5.332, 22.392, 7, 0.398) for the three initial conditions IC1-IC3. In this case, the infection becomes chronic but with persistent humoral immune response. Figures  1-4 demonstrate that, when R G 1 > 1, the humoral immune response is activated and it reduces the concentrations of actively infected cells, latently infected cells and free virus particles and increases the concentration of uninfected cells.
CONCLUSION AND DISCUSSION
In this paper, we have proposed and analyzed three viral infection models with humoral immune response. The models are five dimensional ODEs that describe the interaction between the uninfected target cells, latently infected cells, actively infected cells, free virus particles and B cells. The incidence rate has been represented by bilinear infection rate and saturation functional response in the first and second models, respectively, while it has been given by a more general function in the third one. The neutralization rate of viruses has been given by bilinear form in the first two models, while it is given by a general function in the third one. For each model, we have derived two threshold parameters, the basic infection reproduction number and the humoral immune response activation number. The global stability of the models has been established using Lyapunov method and applying LaSalle's invariance principle. In case of the third model, sufficient conditions have been established which guarantee the global stability of all equilibria of the models. Numerical simulations have been performed for the third model with a special forms of the functions f (x, v) and h(z). We have shown that both numerical and theoretical results are consistent.
6.1. Effects of latently infected cells on the dynamics and controls of viral infection. In this subsection, we show the effect of the presence of latently infected cells on the dynamics and controls of the viral infection. Let us consider two models, the first with latently infected cells and the second without latently infected cells. In both model we incorporate two types of antiviral drugs, reverse transcriptase inhibitors (RTIs) which prevent the virus from infecting the target cells and protease inhibitors (PIs) which prevent the infected cells from producing new infectious viruses. The inclusion of RTIs and PIs allow us to determine the range of drug efficacies that distinguish between the dynamical behaviors of the two models. Model with latently infected cells is given by: .
The model without latently infected cells is given by: It means that, the presence of latently infected cells deceases the two threshold parameters of the system. We note that, the values of the parameters g, r and μ have no impact on the values of R G 0 (u) and R G 0 (u). This fact seems to suggest that, humoral immune response do not play a role in clearing the viruses but can play a significant role in reducing the infection progress. Since the goal is to clear the viruses from the body, then we have to determine the drug efficacies that make R G 0 (u) ≤ 1 and R G 0 (u) ≤ 1 for systems (6.1)-(6.5) and (6.6)-(6.9), respectively. Now, we calculate the critical drug efficacy (i.e, the efficacy needed in order to stabilize the system around the infection-free equilibrium). For system (6.1)-(6.5), E 0 is GAS when R G 0 (u) ≤ 1 i.e., u crit 1 ≤ u < 1,
, For system (6.6)-(6.9), E 0 is GAS when R G 0 (u) ≤ 1 i.e., u crit 2 ≤ u < 1,
Clearly, R G 0 (0) < R G 0 (0) and thus u crit 1 < u crit 2 . Therefore, the drug efficacy necessary to drive the system to the infection-free equilibrium is actually less for system (6.1)-(6.5) than that for system (6.6)-(6.9).
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